Abrdn Life Sciences Investors stock is traded at $17.36, with a volume of 157,085. It is down -5.45% in the last 24 hours and down -1.14% over the past month. abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
Previous Close:
$18.36
Open:
$18.36
24h Volume:
157,085
Relative Volume:
1.47
Market Cap:
$527.88M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.86%
1M Performance:
-1.14%
6M Performance:
-4.72%
1Y Performance:
+8.09%
1-Day Range:
$0.00$0.00
1-Week Range:
$17.30$19.00
52-Week Range:
$15.66$22.67
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences InvestorsSector
FinancialIndustry
Closed-End Fund - EquityPhone
-Address
, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS